Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
53.86 Down 0.75(1.37%) Apr 17, 4:00PM EDT
|After Hours : 53.86 0.00 (0.00%) Apr 17, 4:29PM EDT
Get the big picture on all your investments.
Prev Close:54.61
Open:54.11
Bid:1.00 x 100
Ask:54.55 x 100
1y Target Est:101.00
Beta:2.21
Earnings Date:May 5 - May 9 (Est.)
Day's Range:52.42 - 55.58
52wk Range:21.60 - 112.57
Volume:722,622
Avg Vol (3m):763,243
Market Cap:3.44B
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYDown 1.37%3.44B
MRKUp 0.37%166.06B
PFEUp 0.53%193.08B
VRXUp 0.49%40.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):74.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.89
Quarterly EPS Est (Mar-14) :-0.54
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):4.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback